Postgraduate Medical Journal · 2004 · 27 citations · 11 references
MedicineClinical SciencesImmunologyImmunotherapyInflammationRheumatologyCrohn Disease PharmacotherapyGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory LesionsInflammatory Skin DiseasesInflammatory Skin DisordersCondyloma AcuminatumCutaneous Crohn DiseaseGenital WartsInflammatory Bowel Disease PathologyInflammatory Bowel Disease TherapyMonoclonal Antibody Infusion
Infliximab is a monoclonal antibody against tumour necrosis factor-alpha. Recent studies have shown that it is effective in treating patients with refractory Crohn's disease and in those with Crohn's fistulae. Though this drug is found to be safe in clinical trials, sporadic reports of serious complications have been recorded in the literature. The case of a patient who developed profuse genital warts after infliximab treatment is reported. The literature is reviewed and information is presented on side effects and complications as a result of infliximab therapy.
11
Freddy Cornillie, David J. Shealy, Geert D’Haens et al. · Alimentary Pharmacology & Therapeutics · 2001 · 202 citations · Full text